Cotransplantation of mouse neural stem cells (mNSCs) with adipose tissue-derived mesenchymal stem cells improves mNSC survival in a rat spinal cord injury model
- PMID: 21054952
- DOI: 10.3727/096368910X539083
Cotransplantation of mouse neural stem cells (mNSCs) with adipose tissue-derived mesenchymal stem cells improves mNSC survival in a rat spinal cord injury model
Abstract
The low survival rate of graft stem cells after transplantation into recipient tissue is a major obstacle for successful stem cell therapy. After transplantation into the site of spinal cord injury, the stem cells face not only hypoxia due to low oxygen conditions, but also a lack of nutrients caused by damaged tissues and poor vascular supply. To improve the survival of therapeutic stem cells after grafting into the injured spinal cord, we examined the effects of cotransplanting mouse neural stem cells (mNSCs) and adipose tissue-derived mesenchymal stem cells (AT-MSCs) on mNSC viability. The viability of mNSCs in coculture with AT-MSCs was significantly increased compared to mNSCs alone in an in vitro injury model using serum deprivation (SD), hydrogen peroxide (H(2)O(2)), and combined (SD + H(2)O(2)) injury mimicking the ischemic environment of the injured spinal cord. We demonstrated that AT-MSCs inhibited the apoptosis of mNSCs in SD, H(2)O(2), and combined injury models. Consistent with these in vitro results, mNSCs transplanted into rat spinal cords with AT-MSCs showed better survival rates than mNSCs transplanted alone. These findings suggest that cotransplantation of mNSCs with AT-MSCs may be a more effective transplantation protocol to improve the survival of cells transplanted into the injured spinal cord.
Similar articles
-
Hypoxia-preconditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model.Neurosci Lett. 2010 Mar 26;472(3):215-9. doi: 10.1016/j.neulet.2010.02.008. Epub 2010 Feb 11. Neurosci Lett. 2010. PMID: 20153400
-
Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.Cell Transplant. 2018 Jul;27(7):1126-1139. doi: 10.1177/0963689718780309. Epub 2018 Jun 27. Cell Transplant. 2018. PMID: 29947256 Free PMC article.
-
Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.Acta Biochim Biophys Sin (Shanghai). 2011 Nov;43(11):857-66. doi: 10.1093/abbs/gmr087. Epub 2011 Oct 6. Acta Biochim Biophys Sin (Shanghai). 2011. PMID: 21983658
-
[Transplantation of neural stem cells and bone marrow mesenchymal stem cells in treatment of spinal cord injury].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Feb;26(2):186-9. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012. PMID: 22403882 Review. Chinese.
-
Treatment of spinal cord injury: a review of engineering using neural and mesenchymal stem cells.Clin Anat. 2015 Jan;28(1):37-44. doi: 10.1002/ca.22443. Epub 2014 Aug 23. Clin Anat. 2015. PMID: 25156268 Review.
Cited by
-
Therapeutic Potential of Multilineage-Differentiating Stress-Enduring Cells for Osteochondral Repair in a Rat Model.Stem Cells Int. 2017;2017:8154569. doi: 10.1155/2017/8154569. Epub 2017 Oct 29. Stem Cells Int. 2017. PMID: 29312455 Free PMC article.
-
Stem cell therapy in spinal trauma: Does it have scientific validity?Indian J Orthop. 2015 Jan-Feb;49(1):56-71. doi: 10.4103/0019-5413.143913. Indian J Orthop. 2015. PMID: 25593357 Free PMC article.
-
17β-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury.J Cell Mol Med. 2014 Feb;18(2):326-43. doi: 10.1111/jcmm.12191. Epub 2013 Dec 22. J Cell Mol Med. 2014. PMID: 24373095 Free PMC article.
-
Neurological disorders and the potential role for stem cells as a therapy.Br Med Bull. 2012;101(1):163-81. doi: 10.1093/bmb/lds001. Epub 2012 Feb 21. Br Med Bull. 2012. PMID: 22357552 Free PMC article. Review.
-
Mesenchymal stromal cells for the treatment of Alzheimer's disease: Strategies and limitations.Front Mol Neurosci. 2022 Oct 6;15:1011225. doi: 10.3389/fnmol.2022.1011225. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36277497 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical